NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,963,078 | -18.2% | 937,683 | +0.2% | 0.00% | – |
| Q2 2023 | $3,622,935 | +83.1% | 936,159 | +31.0% | 0.00% | – |
| Q1 2023 | $1,979,176 | -21.7% | 714,504 | -49.1% | 0.00% | – |
| Q4 2022 | $2,527,934 | +82.8% | 1,404,408 | +115.3% | 0.00% | – |
| Q3 2022 | $1,383,000 | -11.4% | 652,325 | +12.4% | 0.00% | – |
| Q2 2022 | $1,561,000 | +93.4% | 580,183 | +212.0% | 0.00% | – |
| Q1 2022 | $807,000 | -12.1% | 185,955 | +4.9% | 0.00% | – |
| Q4 2021 | $918,000 | -5.2% | 177,200 | +12.4% | 0.00% | – |
| Q3 2021 | $968,000 | – | 157,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |